US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 1.1400
  • +0.0100+0.88%
Close Nov 29 13:00 ET
  • 1.1500
  • +0.0100+0.88%
Post 16:04 ET
210.28MMarket Cap-1357P/E (TTM)

About Nektar Therapeutics Company

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Company Profile

SymbolNKTR
Company NameNektar Therapeutics
Listing DateMay 6, 1994
Issue Price7.50
Founded1990
CEOMr. Howard W. Robin
MarketNASDAQ
Employees137
Fiscal Year Ends12-31
Address455 Mission Bay Boulevard South
CitySan Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94158
Phone1-415-482-5300
Websitehttp://www.nektar.com

Company Executives

  • Name
  • Position
  • Salary
  • Howard W. Robin
  • Director, President and Chief Executive Officer
  • 3.14M
  • Mark Andrew Wilson, J.D.
  • Senior Vice President and Chief Legal Officer
  • 1.10M
  • Dr. Jonathan Zalevsky, PhD
  • Chief Research and Development Officer
  • 1.77M
  • Sandra A. Gardiner
  • Interim Chief Financial Officer and Principal Accounting Officer
  • 376.30K
  • Robert B. Chess
  • Chairman of the Board
  • 176.22K
  • R. Scott Greer
  • Independent Director
  • 170.22K
  • Dr. Myriam J. Curet, M.D.
  • Independent Director
  • 118.22K
  • Jeffrey R. Ajer
  • Independent Director
  • 134.22K
  • Roy A. Whitfield
  • Lead Independent Director
  • 170.22K
  • Dr. Diana M. Brainard, M.D.
  • Independent Director
  • 112.72K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data